{"version":"1.0","type":"link","title":"Targeting the atypical chemokine receptor 2 () improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.","author_name":"Noman MZ 외","author_url":"https://prs-insight.online/author/Noman%20MZ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/170220","thumbnail_width":1200,"thumbnail_height":630}